ANIKA THERAPEUTICS INC (ANIK)
US0352551081 - Common Stock
Full estimates are only available for subscribed users, you can see which data is available below.
Subscribed users also see more surprise data, now it is restricted to 4 quarters.
Examples of complete estimate data are available for MSFT and AAPL.
Registered users have access to more data. Please register or login for additional estimates and surprises .
| 2021 | 2022 | 2023 | 2024 | 2025 | 2026 | 2027 | 2028 | ||
|---|---|---|---|---|---|---|---|---|---|
| Revenue YoY % growth | 147.8M 13.26% | 156.2M 5.68% | 166.662M 6.70% | 153.2M -8.08% | 116.79M -23.77% | 126.72M 8.50% | 219.91M 73.54% | 240.01M 9.14% | |
| EBITDA YoY % growth | 16.92M -38.83% | -4.92M -129.08% | -4.949M -0.59% | 17.159M 446.72% | 12.743M -25.74% | 15.543M 21.97% | 44.37M 185.47% | 50.898M 14.71% | |
| EBIT YoY % growth | 2.6M -81.69% | -19.4M -846.15% | -19.166M 1.21% | -35.566M -85.57% | -7.25M 79.62% | -5.163M 28.78% | 14.28M 376.57% | 19.584M 37.14% | |
| Operating Margin | 1.76% | -12.42% | -11.50% | -23.22% | -6.21% | -4.07% | 6.49% | 8.16% | |
| EPS YoY % growth | 0.29 145.31% | -0.89 -406.90% | -5.41 -507.87% | -2.68 50.41% | -0.20 92.40% | 0.36 275.00% | 1.09 205.71% | 1.46 33.64% |
All data in USD
| Q4 / 24 | Q1 / 25 | Q2 / 25 | Q3 / 25 | Q4 / 25 | Q1 / 26 | Q2 / 26 | Q3 / 26 | Q4 / 26 | |
|---|---|---|---|---|---|---|---|---|---|
| EPS Q2Q % growth | -0.02 99.64% | -0.05 85.19% | -0.04 -308.00% | -0.06 77.56% | -0.02 | 0.13 388.89% | 0.23 675.00% | 0.22 500.00% | 0.32 2,166.67% |
| Revenue Q2Q % growth | 38.76M -9.80% | 28.688M -29.21% | 29.58M -29.44% | 28.433M -26.63% | 30.09M -22.37% | N/A | N/A | N/A | N/A |
| EBITDA Q2Q % growth | 2.652M -79.00% | 2.859M 362.78% | 3.075M -31.08% | 3.239M -28.94% | 3.57M 34.62% | N/A | N/A | N/A | N/A |
| EBIT Q2Q % growth | -1.989M -25.02% | -2.089M 33.70% | -1.923M -663.84% | -1.76M -0.49% | -1.479M 25.64% | N/A | N/A | N/A | N/A |
All data in USD
| Period | Reported | Estimate | Difference | Surprise |
|---|---|---|---|---|
| Q3 2024 Q2Q % growth | -0.25 44.44% | -0.02 | -0.23 | -1,533.99% |
| Q2 2024 Q2Q % growth | -0.01 94.74% | 0.05 | -0.06 | -121.01% |
| Q1 2024 Q2Q % growth | -0.31 34.04% | -0.19 | -0.12 | -62.81% |
| Q4 2023 Q2Q % growth | -4.30 -1,164.71% | -0.27 | -4.03 | -1,500.91% |
| Q3 2023 Q2Q % growth | -0.45 -200.00% | -0.38 | -0.07 | -18.17% |
| Q2 2023 Q2Q % growth | -0.19 5.00% | -0.28 | 0.09 | 31.01% |
| Q1 2023 Q2Q % growth | -0.47 -135.00% | -0.31 | -0.16 | -53.59% |
| Q4 2022 Q2Q % growth | -0.34 15.00% | -0.24 | -0.10 | -38.89% |
| Q3 2022 Q2Q % growth | -0.15 -475.00% | -0.26 | 0.11 | 41.18% |
| Q2 2022 Q2Q % growth | -0.20 -144.44% | -0.23 | 0.03 | 13.50% |
| Q1 2022 Q2Q % growth | -0.20 -200.00% | -0.37 | 0.17 | 46.28% |
| Q4 2021 Q2Q % growth | -0.40 -433.33% | -0.26 | -0.14 | -55.31% |
| Q3 2021 Q2Q % growth | 0.04 108.89% | -0.21 | 0.25 | 118.67% |
| Q2 2021 Q2Q % growth | 0.45 221.62% | -0.15 | 0.60 | 400.80% |
| Q1 2021 Q2Q % growth | 0.20 233.33% | -0.13 | 0.33 | 256.86% |
| Q4 2020 Q2Q % growth | 0.12 -72.09% | 0.14 | -0.02 | -15.97% |
| Q3 2020 Q2Q % growth | -0.45 -170.31% | -0.01 | -0.44 | -4,311.76% |
| Q2 2020 Q2Q % growth | -0.37 -154.41% | -0.25 | -0.12 | -48.06% |
| Q1 2020 Q2Q % growth | 0.06 -80.65% | -0.07 | 0.13 | 190.50% |
| Q4 2019 Q2Q % growth | 0.43 -20.37% | 0.43 | 0.00 | 1.18% |
| Q3 2019 Q2Q % growth | 0.64 20.75% | 0.40 | 0.24 | 59.52% |
| Q2 2019 Q2Q % growth | 0.68 | 0.40 | 0.28 | 72.04% |
| Q1 2019 Q2Q % growth | 0.31 167.39% | 0.20 | 0.11 | 57.88% |
| Q4 2018 Q2Q % growth | 0.54 | 0.33 | 0.21 | 61.65% |
| Q3 2018 Q2Q % growth | 0.53 | 0.32 | 0.21 | 66.27% |
| Q2 2018 Q2Q % growth | 0.68 | 0.34 | 0.34 | 102.02% |
| Q1 2018 Q2Q % growth | -0.46 | 0.16 | -0.62 | -390.96% |
| Period | Reported | Estimate | Difference | Surprise |
|---|---|---|---|---|
| Q3 2024 Q2Q % growth | 38.753M -6.54% | 42.924M | -4.171M | -9.72% |
| Q2 2024 Q2Q % growth | 41.921M -5.37% | 42.941M | -1.02M | -2.38% |
| Q1 2024 Q2Q % growth | 40.523M 6.85% | 39.926M | 597K | 1.50% |
| Q4 2023 Q2Q % growth | 42.971M 8.46% | 42.233M | 738K | 1.75% |
| Q3 2023 Q2Q % growth | 41.465M 2.99% | 39.031M | 2.434M | 6.24% |
| Q2 2023 Q2Q % growth | 44.302M 11.70% | 41.368M | 2.934M | 7.09% |
| Q1 2023 Q2Q % growth | 37.924M 3.36% | 38.026M | -102K | -0.27% |
| Q4 2022 Q2Q % growth | 39.62M 10.61% | 38.459M | 1.161M | 3.02% |
| Q3 2022 Q2Q % growth | 40.26M 1.82% | 38.337M | 1.923M | 5.02% |
| Q2 2022 Q2Q % growth | 39.66M 3.96% | 38.609M | 1.051M | 2.72% |
| Q1 2022 Q2Q % growth | 36.69M 7.00% | 33.557M | 3.133M | 9.34% |
| Q4 2021 Q2Q % growth | 35.82M 9.57% | 32.693M | 3.127M | 9.56% |
| Q3 2021 Q2Q % growth | 39.54M 24.77% | 37.044M | 2.496M | 6.74% |
| Q2 2021 Q2Q % growth | 38.15M 24.35% | 35.196M | 2.954M | 8.39% |
| Q1 2021 Q2Q % growth | 34.29M -3.14% | 32.841M | 1.449M | 4.41% |
| Q4 2020 Q2Q % growth | 32.69M 9.81% | 34.17M | -1.48M | -4.33% |
| Q3 2020 Q2Q % growth | 31.69M 6.70% | 30.716M | 974K | 3.17% |
| Q2 2020 Q2Q % growth | 30.68M 0.85% | 20.775M | 9.905M | 47.68% |
| Q1 2020 Q2Q % growth | 35.4M 43.20% | 32.163M | 3.237M | 10.06% |
| Q4 2019 Q2Q % growth | 29.77M 10.42% | 28.121M | 1.649M | 5.86% |
| Q3 2019 Q2Q % growth | 29.7M 10.86% | 27.552M | 2.148M | 7.80% |
| Q2 2019 Q2Q % growth | 30.42M -0.43% | 28.055M | 2.365M | 8.43% |
| Q1 2019 Q2Q % growth | 24.72M 16.27% | 22.322M | 2.398M | 10.74% |
| Q4 2018 Q2Q % growth | 26.96M | 26.689M | 271K | 1.02% |
| Q3 2018 Q2Q % growth | 26.79M | 27.543M | -753K | -2.73% |
| Q2 2018 Q2Q % growth | 30.55M | 28.461M | 2.089M | 7.34% |
| Q1 2018 Q2Q % growth | 21.26M | 24.827M | -3.567M | -14.37% |
| Next Q (1 month) | Next Q (3 month) | Next Year (1 month) | Next Year (3 month) | |
|---|---|---|---|---|
| EPS | 0% | -400% | 0% | -1152.38% |
| Revenue | 0% | -15.43% | 0% | -11.76% |